John Oyler Email

Founder & CEO . BeiGene

Current Roles

Employees:
4667
Revenue:
$1.1B
About
BeiGene, Ltd. (NASDAQ: BGNE) is a global, commercial-stage, research-based biotechnology company focused on molecularly-targeted and immuno-oncology cancer therapeutics. With a team of over 1,300 employees in China, the United States (Cambridge, MA; Fort Lee, NJ; Emeryville, CA & San Mateo, CA), Switzerland and Australia, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for the treatment of cancer. BeiGene is working to create combination solutions aimed at having both a meaningful and lasting impact on cancer patients. For more information, see www.beigene.com.
BeiGene Address
55 Cambridge Parkway
Cambridge, MA
United States
BeiGene Email

Past Companies

BeiGeneFounder & CEO
Biotechnology Innovation OrganizationBoard Member
BioDuroFounder & CEO

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.